+
Site Tour

AV VALVES Summit 2023 Trending Controversies Round 3: TA, TF in TMVR

What have we learned after 3 years of transcatheter mitral valve replacement (TMVR) with Tendyne™ and the future ahead with transfemoral (TF) options? Round 3 of the trending controversies session addresses this topic with Martin Andreas and Lars Søndergaard.

FIND OUT MORE ON AV VALVE SUMMIT 2023:

Watch on Demand videos

Related Videos

AV VALVES 2023: Trending Topics – Timing

AV VALVES 2023: The Genesis of TEER

AV VALVES 2023:HF and VHD – Patient Management

AV VALVES 2023: MR – MAC

AV VALVES 2023: TR – Multileaflet Valve

AV VALVES 2023: Morphology

AV VALVES 2023: Staged, Concomitant

AV VALVES 2023: HoloLens Technology

ESC 2023 Tutorial – TriClip™ | Dr. Sanchis

Javier's testimonial

M-TEER: patient selection and current evidence

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

Transcatheter Mitral Valve implant

TRENDING TOPICS

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

CONNEXT


HUB
RELATED RESOURCES

bRIGHT study

2-year outcomes from the TRILUMINATE Pivotal trial

Safety with TriClip TEER

ACC 2023: COAPT™ trial

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: Staged, Concomitant

Case Transmission | Tricuspid focus

Screening Transmission | Mitral focus

AV Valves Summit 2024 | Closing of Day 2

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline